By Ayo Onikoyi

In what has been adjudged a groundbreaking stride towards bolstering healthcare advancements, Lola Eniodunmo, a researcher at North Dakota State University with collaborations at Los alamos National Laboratory and University of Alabama, has continued to make a mark for herself in the study of organometallic materials for cancer cell research, theranostic photodynamic therapy and bioimaging applications through computations.

For somebody who is pioneering research in computational chemistry among others, Eniodunmo is putting her skills in high performance computing and profound expertise in programming languages to good use. Her research uses computations and predictive modelling to predict the behavior of new materials, support, interpret and provide deep insights into experimental data on benign or cancerous tumor cells.

With her expertise in high performance computing, Python and several quantum chemistry techniques, Lola has made significant contributions to the field of photodynamic therapy of cancer cells through atomistic modelling of the mechanisms and processes which takes place at the bio interface of the photosensitizers for photodynamic therapy and optical sensing.

She noted that her meticulous analysis and innovative approach have led to the development of novel techniques for enhancing the functionality of these materials. With her research, she has been able to provide insights into phenomena that are impossible to probe on an experimental level. Using her proficiency in simulations and computations, Omolola has been able to explain trends and behavior of dynamic processes in these organometallic complexes predicted to combat cancerous cells. This has global implications on driving innovation and advancing healthcare worldwide.

Omolola’s current research on developing new earth-abundant and cost-effective complexes with highly efficient emission properties suitable for photodynamic and photothermal studies is worth over USD1 million. Her contribution to cancer cell research goes beyond explaining observed trends from experiments, she is also able to predict completely new structures and their specific behavior in the body.

This has the potential to enhance precision medicine and drug discovery destroy cancer cells which in turn provides a 70% time and cost saving for experimentalists. This shows Lola’s collaborative efforts with experimentalists to streamline research processes and optimize resource utilization.

With a promising implication for healthcare innovation and potential applications in pharmaceuticals and medical diagnostic tools, her work paves the way for the development of next-generation technologies that promise to revolutionize healthcare delivery and improve patient outcomes.

In alignment with the Department of Energy’s objectives, Lola’s research also contributes to research in electronics, optoelectronics, defense, security, energy conversion and storage. Additionally, her efforts support the National Science Foundation’s goals through fostering economic growth and creating job opportunities within the United States.

With unwavering commitment to excellence and innovative approach that underscores her status as a trailblazer in the field, Eniodunmo is dotting the future landscape of scientific research and technological innovation in style.